Key Dates

Related Announcements

PAS-22-197 - Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

Issued by

National Institute on Aging (NIA)

Purpose

This Notice corrects the Application Types Allowed information provided in Funding Opportunity Announcement (FOA) PAS-22-197, “Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional).” Specifically, this Notice removes “Direct” as an allowable application type.

The following section of PAS-22-197 has been modified:

Part 2. Full Text of Announcement

Section II. Award Information

Application Types Allowed

Currently Reads (the information being removed is shown in bold italics):

New
Phase I, Phase II, Fast-Track, Direct

Renewal -
Renewals of Phase II and Phase IIB only

Resubmission -
All Phases

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for the FOA.

Modified to Read:

New
Phase I, Phase II, Fast-Track

Renewal -
Renewals of Phase II and Phase IIB only

Resubmission -
All Phases

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for the FOA.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Zane Martin, Ph.D.
National Institute on Aging (NIA)
Division of Neuroscience (DN)
Telephone: 301-827-7130
Email: zane.martin@nih.gov

Michael-David ARR Kerns, M.M., M.S., Ph.D.
National Institute on Aging (NIA)
NIA SBIR-STTR Program Coordinator
Telephone: 301-402-7713
Email: niasmallbusiness@mail.nih.gov

Emily Laura Caporello, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Phone: 301-496-1779
E-mail: emily.caporello@nih.gov